+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030- Product Image
Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030- Product Image
Sale

Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985895
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vaccines Market size was estimated at USD 55.66 billion in 2023, USD 59.94 billion in 2024, and is expected to grow at a CAGR of 7.79% to reach USD 94.14 billion by 2030.

Vaccines are biological preparations that equip the body's immune system with the capability to combat disease-causing microbes effectively. They work by stimulating the immune response to generate a specific defense mechanism, predominantly in the form of antibodies, against harmful pathogens. The rising incidence of infectious diseases globally and the rise in immunization programs worldwide significantly influence this growth. Moreover, favorable government initiatives and policies for vaccine development are also driving market growth. High development costs, lengthy testing and approval process issues over product recalls, and inaccessibility in a few regions pose challenges to the growth of the vaccine market. Integration of adjuvants in vaccines, development of therapeutic vaccines, and growth in the contract manufacturing of the vaccines are expected to create significant growth opportunities in the market.

Regional Insights

In Asia-Pacific, robust economies such as China, India, and Japan have exhibited significant growth in vaccine markets due to large population densities and high prevalence of infectious diseases, necessitating comprehensive immunization drives. There's a high need for vaccines in the Americas, comprising countries such as the United States and Canada, owing to the demographic makeup and an expansive public health infrastructure. Significant investments in research and development (R&D) of vaccines, recent patents, and initiatives further fuel the growth. The EMEA region, with diverse economic landscapes, displays varying consumer behavior. The European Union, with well-funded health systems, necessitates extensive immunization programs. The Middle East and Africa possess a significant potential for market growth. Initiatives such as the collaboration between the Serum Institute of India and the Africa Vaccine Acquisition Trust in 2022 to supply COVID-19 vaccines are pivotal changes reshaping this landscape.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vaccines Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca PLC, Bavarian Nordic A/S, Bharat Biotech Ltd., Biological E. Limited, Chongqing Zhifei Biological Products Co.,Ltd., CSL Limited, CureVac SE, Daiichi Sankyo Co., Ltd., Emergent BioSolutions Inc., Gennova Biopharmaceuticals Limited, GlaxoSmithKline PLC, Inovio Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Merck KGaA, Mitsubishi Chemical Group Corporation, Moderna Inc., Novavax, Inc., Pfizer Inc., Sanofi Group, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Takeda Pharmaceutical Company Limited, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Monovalent Vaccine
    • Multivalent Vaccine
  • Technology Type
    • Inactivated Vaccines
    • Live-Attenuated Vaccines
    • Messenger RNA (mRNA) Vaccines
    • Subunit, Recombinant, Polysaccharide, & Conjugate Vaccines
    • Toxoid Vaccines
    • Viral Vector Vaccines
  • Indication
    • DPT
    • Hepatitis
    • Human Papillomavirus
    • Influenza
    • Measles
    • Meningococcal Disease
    • Mumps & Rubella
    • Pneumococcal Disease
    • Polio
    • Rotavirus
    • Varicella
  • Route of administration
    • Intramuscular & Subcutaneous
    • Oral
  • Age Group
    • Adults
    • Pediatric
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Vaccines Market?
  4. What is the market share of the leading vendors in the Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Vaccines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Vaccines Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of infectious diseases globally
5.1.1.2. Favorable government initiatives and policies for vaccine development
5.1.1.3. Growing focus on immunization across the world
5.1.2. Restraints
5.1.2.1. High development costs, lengthy testing and approval processes
5.1.3. Opportunities
5.1.3.1. Integration of adjuvants in vaccines and development of therapeutic vaccines
5.1.3.2. Growth in the contract manufacturing of the vaccines
5.1.4. Challenges
5.1.4.1. Issues over product recalls and inaccessibility in few regions
5.2. Market Segmentation Analysis
5.2.1. Type: Significant preference for monovalent vaccines for specific disease prevention
5.2.2. Technology Type: Rising development in the conjugate vaccines as an viable alternative
5.2.3. Indication: Growing need for DPT vaccine for protection against serious respiratory ailments
5.2.4. Route of administration: Increasing adoption of oral vaccines for longer-lasting immune responses
5.2.5. Age Group: wider adoption of pediatric vaccine as a preventive measure owing to rising HPV vaccine usability
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Vaccines Market, by Type
6.1. Introduction
6.2. Monovalent Vaccine
6.3. Multivalent Vaccine
7. Vaccines Market, by Technology Type
7.1. Introduction
7.2. Inactivated Vaccines
7.3. Live-Attenuated Vaccines
7.4. Messenger RNA (mRNA) Vaccines
7.5. Subunit, Recombinant, Polysaccharide, & Conjugate Vaccines
7.6. Toxoid Vaccines
7.7. Viral Vector Vaccines
8. Vaccines Market, by Indication
8.1. Introduction
8.2. DPT
8.3. Hepatitis
8.4. Human Papillomavirus
8.5. Influenza
8.6. Measles
8.7. Meningococcal Disease
8.8. Mumps & Rubella
8.9. Pneumococcal Disease
8.10. Polio
8.11. Rotavirus
8.12. Varicella
9. Vaccines Market, by Route of administration
9.1. Introduction
9.2. Intramuscular & Subcutaneous
9.3. Oral
10. Vaccines Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Pediatric
11. Americas Vaccines Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Vaccines Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Vaccines Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Agreement, Collaboration, & Partnership
14.3.1.1. BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
14.3.2. Award, Recognition, & Expansion
14.3.2.1. Oxford R21/Matrix-M Malaria Vaccine Receives WHO Recommendation for Use
14.3.2.2. Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Astellas Pharma Inc.
15.1.3. AstraZeneca PLC
15.1.4. Bavarian Nordic A/S
15.1.5. Bharat Biotech Ltd.
15.1.6. Biological E. Limited
15.1.7. Chongqing Zhifei Biological Products Co.,Ltd.
15.1.8. CSL Limited
15.1.9. CureVac SE
15.1.10. Daiichi Sankyo Co., Ltd.
15.1.11. Emergent BioSolutions Inc.
15.1.12. Gennova Biopharmaceuticals Limited
15.1.13. GlaxoSmithKline PLC
15.1.14. Inovio Pharmaceuticals, Inc.
15.1.15. Johnson & Johnson Services, Inc.
15.1.16. Merck KGaA
15.1.17. Mitsubishi Chemical Group Corporation
15.1.18. Moderna Inc.
15.1.19. Novavax, Inc.
15.1.20. Pfizer Inc.
15.1.21. Sanofi Group
15.1.22. Serum Institute of India Pvt. Ltd.
15.1.23. Sinovac Biotech Ltd.
15.1.24. Takeda Pharmaceutical Company Limited
15.1.25. Zydus Lifesciences Limited
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. VACCINES MARKET RESEARCH PROCESS
FIGURE 2. VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VACCINES MARKET DYNAMICS
FIGURE 7. VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2030 (%)
FIGURE 10. VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 14. VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 16. VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. VACCINES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. VACCINES MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VACCINES MARKET SIZE, BY MULTIVALENT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 9. VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VACCINES MARKET SIZE, BY MESSENGER RNA (MRNA) VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 16. VACCINES MARKET SIZE, BY DPT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. VACCINES MARKET SIZE, BY MENINGOCOCCAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. VACCINES MARKET SIZE, BY MUMPS & RUBELLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. VACCINES MARKET SIZE, BY VARICELLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. VACCINES MARKET SIZE, BY INTRAMUSCULAR & SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 31. VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. CANADA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. MEXICO VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. CHINA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. CHINA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 78. CHINA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. CHINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. CHINA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. INDIA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDIA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. INDIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. INDIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. JAPAN VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. JAPAN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 93. JAPAN VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. JAPAN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. JAPAN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. THAILAND VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. THAILAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 123. THAILAND VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. THAILAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. THAILAND VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. DENMARK VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 139. DENMARK VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. DENMARK VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. DENMARK VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 142. EGYPT VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 144. EGYPT VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. EGYPT VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. EGYPT VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. FINLAND VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FINLAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. FINLAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. FINLAND VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. FRANCE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. FRANCE VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. GERMANY VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. GERMANY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. ITALY VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 169. ITALY VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. ITALY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. ITALY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 182. NORWAY VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 184. NORWAY VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. NORWAY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. NORWAY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. POLAND VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. POLAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 189. POLAND VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. POLAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. POLAND VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. QATAR VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. QATAR VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 194. QATAR VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. QATAR VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. QATAR VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. SPAIN VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. SPAIN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. TURKEY VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 242. VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 243. VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 244. VACCINES MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech Ltd.
  • Biological E. Limited
  • Chongqing Zhifei Biological Products Co.,Ltd.
  • CSL Limited
  • CureVac SE
  • Daiichi Sankyo Co., Ltd.
  • Emergent BioSolutions Inc.
  • Gennova Biopharmaceuticals Limited
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Mitsubishi Chemical Group Corporation
  • Moderna Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi Group
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 59.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 94.14 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Forecast 2024-2030 - Product Image

Global Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global Shingles Vaccine Market by Product (SkyZoster, Zostavax, ??Shingrix), Type (Live Attenuated Vaccine, Recombinant Vaccine) - Forecast 2024-2030 - Product Image

Global Shingles Vaccine Market by Product (SkyZoster, Zostavax, ??Shingrix), Type (Live Attenuated Vaccine, Recombinant Vaccine) - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical Regions (North America, Europe and Asia-Pacific) and Leading Players: Industry Trends and Global Forecasts, 2023-2035 - Product Image

RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical Regions (North America, Europe and Asia-Pacific) and Leading Players: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • 170 Pages
  • Global
From
mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

mRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 159 Pages
  • Global
From
mRNA Vaccines Market Report 2023-2033 - Product Image

mRNA Vaccines Market Report 2023-2033

  • Report
  • 215 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.